Silicon Investor (SI) -- The First Internet Community

To: Jibacoa who wrote (5882)

2/23/2012 9:15:24 AM

OREX is also up 23% on premarket trading.<g>
bigcharts.marketwatch.com

The stock is also participating from the FDA panel recommendations on VVUS's Qnexa
As previously mentioned, OREX has already planned a PIII to demonstrate that Contrave does not unacceptably increase the risk of major adverse cardiovascular events. <g>

Bernard